Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,000
Closed -$47.8K 436
2025
Q2
$47.8K Sell
10,000
-2,498
-20% -$14.3K 0.01% 406
2025
Q1
$108K Buy
12,498
+2,000
+19% +$21K 0.02% 360
2024
Q4
$127K Sell
10,498
-5,295
-34% -$74.1K 0.02% 355
2024
Q3
$265K Hold
15,793
0.05% 303
2024
Q2
$247K Sell
15,793
-5,060
-24% -$70.3K 0.05% 272
2024
Q1
$329K Hold
20,853
0.07% 219
2023
Q4
$419K Hold
20,853
0.09% 196
2023
Q3
$387K Sell
20,853
-469
-2% -$10.2K 0.1% 192
2023
Q2
$464K Buy
21,322
+3,182
+18% +$57.5K 0.11% 174
2023
Q1
$336K Buy
+18,140
New +$341K 0.08% 208

Other funds holding NEOG

Chicago Trust's NEOG Position: Q3 2025 in Review

Chicago Trust sold out of Neogen (NEOG) in Q3 2025, closing a stake of 10,000 shares — an estimated $47.8K sold.

Chicago Trust first reported a position in NEOG in Q1 2023 and held it in 10 quarters. The position peaked at $464K in Q2 2023. 299 funds tracked by Wall St. Rank hold NEOG as of Q3 2025.

  • Chicago Trust reported no remaining Neogen position as of Q3 2025 after selling out during the quarter.
  • Chicago Trust sold 10,000 Neogen shares in Q3 2025, an estimated $47.8K.
  • Chicago Trust first reported a position in Neogen in Q1 2023 and held it in 10 quarters.
  • Chicago Trust's Neogen position peaked at $464K in Q2 2023.
  • 299 funds tracked by Wall St. Rank held Neogen as of Q3 2025.

Based on Chicago Trust's 13F filing for Q3 2025, filed 10 Oct 2025.